# Relmada Therapeutics, Inc. (RLMD)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RLMD)

## Price

| Indicator | Value |
| --- | --- |
| Current Price | $ 6.90 |
| Market Cap | $ 506.15M |

## Valuation

Widest P/E window this company has the history to fill: 14 years. Shorter windows are still computed; longer ones are left empty rather than padded.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.08 |
| Current Ratio | 18.26 |

## Other views

- [Charts](https://sponda.capital/en/RLMD/charts.md)
- [Fundamentals](https://sponda.capital/en/RLMD/fundamentals.md)
- [Compare](https://sponda.capital/en/RLMD/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.